Project Number 1R43AG067894-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Targeted ultrasound contrast agents for the disruption of Alzheimer's plaques. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator UNGER, WYATT DANIEL Principal Investigator First Name WYATT Principal Investigator Last Name UNGER Awardee Organization MICROVASCULAR THERAPEUTICS, LLC Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $411,171 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
